Leiomyosarcoma of the portal vein: a case report and review of the literature by Lee, JK et al.
Title Leiomyosarcoma of the portal vein: a case report and review ofthe literature
Author(s) Chiu, WHK; Lo, AWI; Lee, JK
Citation BJR Case Reports, 2017, v. 3, p. 20160125
Issued Date 2017
URL http://hdl.handle.net/10722/244903
Rights This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Received:
07 October 2016
Revised:
23 November 2016
Accepted:
06 December 2016
Cite this article as:
Chiu WHK, Lo AWI, Lee JKT. Leiomyosarcoma of the portal vein: a case report and review of the literature. BJR Case Rep 2016; 2:
20160125.
CASE REPORT
Leiomyosarcoma of the portal vein: a case report and
review of the literature
1WAN HANG KEITH CHIU, MBChB, FRCR, 2ANTHONY WI LO, MBChB, FHKC (Path) and 3JOSEPH KT LEE, MD, FACR
1Department of Diagnostic Radiology, The University of Hong Kong, Pokfulam, Hong Kong
2Anatomical Pathology Division, Queen Mary Hospital, Pokfulam, Hong Kong
3Department of Radiology, UNC School of Medicine, Chapel Hill, NC, USA
Address correspondence to: Dr Wan Hang Keith Chiu
E-mail: kwhchiu@hku.hk
ABSTRACT
Leiomyosarcomas (LMS) are rare malignant tumours of smooth muscle origin predominately affecting females in their
sixth decade. Only 2% of LMS arise from blood vessels and most are in the inferior vena cava. We present the first
reported case of LMS of the portal vein in a male patient. Multidetector CT showed a large mass in the main portal vein,
which was initially misinterpreted as a pancreatic cancer. Careful examination of the multidetector CT images showed
radiological features of an intraluminal mass, and a preoperative diagnosis of primary LMS of the main portal vein was
made. The patient underwent curative surgery and made an uneventful recovery. Awareness of this entity and
recognition of the salient CT features may facilitate radiologists in making the correct preoperative diagnosis.
BACKGROUND
Leiomyosarcomas (LMS) are rare malignant tumours of
smooth muscle origin, accounting for only 5–7% of soft tis-
sue sarcomas. They predominantly affect females in the
sixth decade of life and generally occur in the abdomen or
the limbs. Only around 2% of LMS arise from the smooth
muscle of the vessel wall, and the most common site is the
inferior vena cava (IVC).1,2
LMS of the portal vein is extremely rare with four previous
reports in the English literature, all of which were in
females.3–6 In this article, we present the first reported case
of LMS of the portal vein in a male patient with special
emphasis on imaging findings seen on multidetector CT
(MDCT) and positron emission tomography followed by a
brief review of the existing literature.
CASE REPORT
A 67-year-old male initially underwent contrast-enhanced
multidetector CT of the abdomen in Sept 2014 at another
hospital, which showed an incidental 4.2 3.9 cm mass in
the upper abdomen. This was interpreted as a head of pan-
creas mass causing portal vein compression. The patient
was asymptomatic; physical and laboratory examinations
were all unremarkable.
The patient was lost to follow-up and did not receive any
further investigation or treatment. Although still asymp-
tomatic, he re-presented 12months later for a repeat
MDCT, which showed that the mass had increased in size
to 4.8 5.0 cm. Cavernous transformation of the portal
vein was also observed. The patient underwent exploratory
laparotomy, which showed a tumour at the upper border
of the pancreas and duodenum compressing the portal
vein. A 1-cm lesion in the subcapsular aspect of segment II
of the liver was also seen. The presumed pancreatic tumour
was deemed unresectable and multiple biopsies were taken.
The liver lesion was resected and the histology of both
samples showed spindle cell tumour. The patient also
underwent a positron emission tomography-CT, which
showed the lesion to be hypermetabolic with SUVmax
of 7.3. No metastatic disease was identified.
The patient was then referred to the hepatobiliary team in
Queen Mary Hospital in Hong Kong for further assess-
ment. The patient remained asymptomatic clinically with
normal laboratory results including liver biochemistry
(bilirubin 4mmol l–1, alkaline phosphatase 54 U l–1, alanine
aminotransferase 29 U l–1 and aspartate aminotransferase
23 U l–1). A repeat MDCT 2months later showed that
the lesion had a soft tissue density on non-contrast scans.
The mass now measured 5.3 5.9 6.4 cm, extending
from the superior mesenteric vein/splenic vein confluence
to the porta hepatis. It exhibited heterogeneous enhance-
ment with feeding vessels seen on the arterial phase, both
within and around the mass. On the portal venous phase,
numerous collaterals were seen surrounding the mass with
a sharp interface between the mass and opacified portion
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of the main portal vein at the porta hepatis giving the appear-
ance of a “beak” (Figure 1). The pancreatic duct was mildly
dilated and measures 3mm. The biliary tree was not dilated.
There was splenomegaly measuring 13.5 cm craniocaudally. No
gastroesophageal varices or ascites was appreciated. Based on
these MDCT and histological findings, a preoperative diagnosis
of primary leiomyosarcoma of the main portal vein was made.
The patient underwent Whipple’s procedure and portal vein
reconstruction using cadaveric graft. Intraoperative findings
confirmed the tumour arising from inside the portal vein and
confined to the lumen with no macroscopic evidence of disease
spread. Histological examination of the tumour showed spindle
cells with enlarged, pleomorphic, hyperchromatic nuclei and
abundant eosinophilic cytoplasm. Patchy coagulative necrosis
was also seen. Mitotic figures were at 8 per 50 high power fields,
and atypical mitotic figures were found. There was focal infiltra-
tion into adjacent pancreatic parenchyma. Immunohistochemi-
cal stains showed the tumour was positive for actin,
h-caldesmon and desmin but negative for myogenin, c-kit and
S100 protein. The final histological diagnosis was of a primary
LMS of the portal vein (Figure 2). The patient made an unevent-
ful recovery and no adjuvant radiotherapy or chemotherapy was
given. He was followed up for 4 months in our institute with
no complications.
DISCUSSION
Differential diagnoses of a portovenous mass could be “bland
thrombus” or tumour thrombus from malignant aetiology
including pancreatic adenocarcinoma, hilar cholangiocarcinoma
and hepatocellular carcinoma. Distinguishing the two types of
thrombus is essential as it significantly affects treatment options
and prognosis. As in our case, enlargement of the PV and dem-
onstration of feeding vessels within the thrombus indicate the
presence of tumour thrombus rather than bland thrombus.7
Given the close proximity of the PV to pancreas, it is under-
standable that the lesion was initially misinterpreted as a pri-
mary pancreatic lesion causing portal vein thrombosis. In
retrospect, the lack of concurrent dilated common bile and
pancreatic ducts should make this diagnosis less likely.8 As for
hepatocellular carcinoma and cholangiocarcinoma, tumour
thrombus is often caused by direct invasion of the portal
vein.9,10 Without a visible lesion in the adjacent liver
Figure 1. Multiplanar contrast-enhanced multidetector CT images reveal a mass in the portal vein (*). Axial CT image (a) shows
numerous collaterals around the heterogeneously enhancing mass (*). There is a rim of contrast around the mass (white
arrowheads) indicating that themass has an intraluminal origin rather than tumour invasion from adjacent structures. Corresponding
coronal CT image (b) shows a sharp interface with the appearance of a “beak” (white arrowheads) between the opacified main por-
tal vein and the mass (*).
Figure 2. Microscopic findings of the resected specimen
showing the leiomyosarcoma arising from within the portal
vein and confined in the lumen (hematoxylin-eosin, 200
magnification).
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parenchyma or in the hepatobiliary tract, these two differential
diagnoses are also less likely. The identification of a rim of con-
trast around the lesion and “beak” appearance at the interface
between the opacified portion of the PV and the mass further
support the intraluminal nature in this case. While increased
fludeoxyglucose uptake suggested malignant aetiology of the
lesion, the presence of cavernous transformation of the portal
vein and portal hypertension points to chronicity of the portal
vein occlusion, a feature of a less aggressive lesion such as LMS.
These patients are often asymptomatic although they can cause
Table 1. Demographics, clinical characteristics, management and outcome of previous case reports of leiomyosarcoma of the porto-
venous system
Author Age/Sex Location Tumour size Presentation Treatment Outcome
Wilson6 &
Madariaga4
28F PV 3.04.72.7
cm
Abdominal pain Mesocaval
shunt, TR, VR,
RT
Alive at 6years
FU
Sundaresan5 67F Intrahepatic
Left PV
30 15 10cm Epigastric pain Hepatectomy,
TR
Not reported
Boudjema3 44F PV 3cm Jaundice, pruri-
tus, anorexia
cephalic duo-
deno-pancrea-
tectomy, TR,
VR
Recurrence at
27months after
surgery; died
20months after
recurrence
Our patient 67M PV 5.35.96.4
cm
Incidental Liver wedge re-
section, Whip-
ple procedure,
TR and VR
Alive at
6months FU
Goldin17 40F SMV 65.38cm Epigastric pain Hepatectomy,
TR, VR and RT
Alive at
12months FU
Celdran18 60M SMV 4cm Epigastric pain Hemicolect-
omy, TR and VR
Alive at
6months FU
Leporrier19 50M SMV 3cm Epigastric pain Whipple proce-
dure, TR and
VR
Alive at
18months FU
Kumar20 62F SMV 13 107cm Incidental Hemicolect-
omy, hepatect-
omy, TR, VR
and CT
Alive at
33months FU
Clemente21 66F IMV – Lower abdom-
inal pain
Left colon re-
section, TR
Alive at
24months FU
Cimino22 64M IMV 10cm General dis-
comfort
Liver wedge re-
section, jejunal
resection and
TR
Alive with me-
tastases at
13months FU
Rodl23 67M SV 1565 cm Epigastric pain Distal spleno-
pancreatect-
omy
Alive at
36months FU
Niver24 &
Gage25
58F SV 3.533cm Epigastric pain Distal spleno-
pancreatect-
omy, VR
Alive at
15months FU
Aguilar26 66F SV 1296cm Epigastric pain Distal spleno-
pancreatect-
omy, CT
Alive at
12months FU
Patrono27 58F SV 1.5 cm Epigastric pain Local excision,
end-to-end
splenic vein
anastomosis
Alive at
12months FU
PV, portal vein; SMV, superior mesenteric vein; IMV, inferior mesenteric vein; SV, splenic vein; TR, tumour resection; VR, venous recon-
struction; RT, radiotherapy; CT, chemotherapy; FU, Follow up; F, Female; M, Male.
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constitutional symptoms or non-specific abdominal pain.11 The
slow-growing rate of this tumour results in insidious develop-
ment of significant venous obstruction by allowing time for
development of collateral circulation.12 Based on the radiological
features, a primary PV neoplasm is the most likely diagnosis and
LMS is the most common vascular neoplasm. The available his-
tology further adds credence to this diagnosis while the resected
liver lesion is considered a solitary metastasis.
LMS is divided into three major groups based on the origin of
the tumour: soft tissue, cutaneous and vascular.13 LMS involving
the vasculature is the least common and around 50% of them
arise from the IVC. To date, approximately 300 cases have been
reported in the literature.14 LMS in the PV is extremely rare and
to the authors’ knowledge, there are only four previous reports
of LMS in the PV, all of which were in females3–6 LMS involving
other parts of the portovenous system are also rare and the pub-
lished case reports in English are summarized in Table 1.
The classical appearance of LMS on MDCT is a circumscribed
soft tissue mass, often with necrosis, cystic degeneration and
haemorrhage.15,16 This contrasts with the radiological
description of LMS of the PV. Wilson6 described a lesion filling
and expanding the lumen of the PV on ultrasound imaging.
Madariaga4 confirmed the intraluminal nature of the lesion in
surgery. Sundaresan5 described a nodular vascular tumour
within the left lobe of the liver and three smaller satellite lesions
in the right lobe, all of which had enhancement characteristics
of haemangioma on CT. Histological examination showed a
vein with pleomorphic cells streaming out from the media.
Boudjema3 showed an enhancing lesion adjacent to the PV
compressing the common bile duct. The tumour was found on
the PV intraoperatively. The varied appearances correlate with
different degrees of extravascular components of the tumours
and the appearance in the current case reflects the completely
intraluminal nature of the tumour, similar to those described by
Wilson and Madariaga.4,6
As in other LMS, surgical resection with or without venous
reconstruction is the treatment of choice for this group of
patients. Adjuvant chemotherapy and radiotherapy were used in
some cases although the evidence of the efficacy of these treat-
ments is limited owing to the rarity of these cases. In general, for
LMS in the IVC, the overall 5-year survival rate is 49% with up
to 50% recurrence within 30months. For non-IVC LMS, the 4-
year survival rate is 32%.2,11 The resection margin, tumour size
and degree of tumour differentiation are thought to be impor-
tant factors to overall survival.15 In our case, the patient under-
went surgery without adjuvant treatment as the tumour was
deemed to be of low grade.
LEARNING POINTS
1. LMS of the PV is rare. Surgical resection is currently the
only realistic chance of cure and long-term surveillance
after resection is recommended given the high potential
for recurrence and metastatic disease. Awareness of this
entity and recognition of the salient CT features as
described may facilitate radiologists in making the correct
preoperative diagnosis.
CONSENT
Written informed consent for the case to be published
(including images, case history and data) was obtained from the
patient(s) for publication of this case report, including
accompanying images.
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